Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 6

1.

Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma.

Siegelman M, Mohabeer A, Fahey TJ 3rd, Tomlinson G, Mayambala C, Jafari S, Noll WW, Thibodeau SN, Dawson DB.

Clin Chem. 1997 Mar;43(3):453-7.

2.
3.

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hüfner M, Wohllk N, Opocher G, Dvořáková S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorländer C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wüster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP; International RET Exon 10 Consortium.

Hum Mutat. 2011 Jan;32(1):51-8. doi: 10.1002/humu.21385.

PMID:
20979234
4.

Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.

Moore SW, Zaahl M.

J Pediatr Surg. 2010 Feb;45(2):393-6. doi: 10.1016/j.jpedsurg.2009.10.080.

PMID:
20152359
5.

Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.

Moore SW, Appfelstaedt J, Zaahl MG.

J Pediatr Surg. 2007 Feb;42(2):326-32.

PMID:
17270543
6.

Pyrosequencing technology as a method for the diagnosis of multiple endocrine neoplasia type 2.

Kruckeberg KE, Thibodeau SN.

Clin Chem. 2004 Mar;50(3):522-9. Epub 2004 Jan 12.

Supplemental Content

Support Center